Yu Shen

17.3k total citations
292 papers, 8.8k citations indexed

About

Yu Shen is a scholar working on Oncology, Cancer Research and Statistics and Probability. According to data from OpenAlex, Yu Shen has authored 292 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Oncology, 81 papers in Cancer Research and 59 papers in Statistics and Probability. Recurrent topics in Yu Shen's work include Breast Cancer Treatment Studies (58 papers), Statistical Methods and Inference (42 papers) and Global Cancer Incidence and Screening (31 papers). Yu Shen is often cited by papers focused on Breast Cancer Treatment Studies (58 papers), Statistical Methods and Inference (42 papers) and Global Cancer Incidence and Screening (31 papers). Yu Shen collaborates with scholars based in United States, China and Spain. Yu Shen's co-authors include Jing Qin, Sijin Wen, Randall E. Millikan, Arlene O. Siefker‐Radtke, Jing Ning, Colin P. Dinney, Isabelle Bedrosian, Stephen W. Fesik, Elihu H. Estey and Louis L. Pisters and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yu Shen

277 papers receiving 8.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yu Shen 3.1k 2.4k 2.0k 1.9k 1.1k 292 8.8k
Christophe Le Tourneau 4.9k 1.6× 2.1k 0.9× 1.3k 0.7× 1.6k 0.8× 2.3k 2.0× 335 8.7k
B. Nebiyou Bekele 3.8k 1.2× 3.9k 1.6× 729 0.4× 1.4k 0.8× 3.3k 2.9× 137 10.3k
Sin‐Ho Jung 2.7k 0.9× 1.6k 0.6× 1.0k 0.5× 602 0.3× 1.8k 1.6× 299 8.1k
Rajeshwari Sridhara 4.8k 1.5× 3.0k 1.2× 557 0.3× 1.3k 0.7× 2.9k 2.5× 137 9.3k
Gary Longton 1.6k 0.5× 1.3k 0.5× 1.5k 0.8× 627 0.3× 1.3k 1.1× 87 7.1k
Matthew R. Sydes 4.0k 1.3× 1.8k 0.7× 3.0k 1.5× 2.0k 1.1× 7.9k 6.9× 234 15.2k
Alberto Ocaña 7.3k 2.4× 3.8k 1.6× 950 0.5× 2.5k 1.3× 2.5k 2.2× 302 12.3k
Nicholas D. James 4.7k 1.5× 3.1k 1.3× 3.2k 1.6× 2.5k 1.3× 7.1k 6.2× 344 13.6k
Patricia Keegan 5.0k 1.6× 2.1k 0.8× 726 0.4× 1.6k 0.9× 3.1k 2.7× 140 9.3k
Kristine Broglio 7.2k 2.3× 1.9k 0.8× 1.4k 0.7× 4.3k 2.2× 2.6k 2.3× 148 12.3k

Countries citing papers authored by Yu Shen

Since Specialization
Citations

This map shows the geographic impact of Yu Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Shen more than expected).

Fields of papers citing papers by Yu Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Shen. The network helps show where Yu Shen may publish in the future.

Co-authorship network of co-authors of Yu Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Shen. A scholar is included among the top collaborators of Yu Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Shen. Yu Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Shiyang, Yongqiang Guan, & Yu Shen. (2025). A Stackelberg game for optimal control energy of multi-agent networks under cyber-attacks. International Journal of Control. 99(1). 164–175.
2.
Dong, Wenli, Takeo Fujii, Jing Ning, et al.. (2025). Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modeling. Scientific Reports. 15(1). 5590–5590. 2 indexed citations
3.
Zhou, Ziyu, et al.. (2025). Dual‐Selection Strategy for Generating Knock‐Out Lines of Human Embryonic Stem Cells. Journal of Cellular and Molecular Medicine. 29(2). e70259–e70259.
4.
Shen, Yu, Yi Wang, & Peng Huang. (2025). Effects of exercise during pregnancy on maternal and newborn outcomes. BMC Pregnancy and Childbirth. 25(1). 1158–1158.
5.
Niu, Jiangong, Martin C. Tammemägi, Ehsan Irajizad, et al.. (2024). Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework. JNCI Journal of the National Cancer Institute. 116(11). 1798–1806. 4 indexed citations
6.
Shen, Yu, et al.. (2024). Alumni network, mutual fund herding and information spillover: Evidence from China. Pacific-Basin Finance Journal. 83. 102265–102265. 1 indexed citations
7.
Kuerer, Henry M., Gaiane M. Rauch, Savitri Krishnamurthy, et al.. (2023). 243MO Omission of breast surgery after neoadjuvant systemic therapy for invasive cancer: Three-year preplanned primary-endpoint on a phase II multicentre prospective trial. Annals of Oncology. 34. S280–S280. 1 indexed citations
8.
Li, Ziyi, Yu Shen, & Jing Ning. (2023). Accommodating Time-Varying Heterogeneity in Risk Estimation under the Cox Model: A Transfer Learning Approach. Journal of the American Statistical Association. 118(544). 2276–2287. 7 indexed citations
9.
Pak, Daewoo, Jun Liu, Jing Ning, Guadalupe Gómez Melis, & Yu Shen. (2020). Analyzing left‐truncated and right‐censored infectious disease cohort data with interval‐censored infection onset. Statistics in Medicine. 40(2). 287–298. 2 indexed citations
10.
Pak, Daewoo, Klaus Langohr, Jing Ning, et al.. (2020). Modeling the Coronavirus Disease 2019 Incubation Period: Impact on Quarantine Policy. Mathematics. 8(9). 1631–1631. 9 indexed citations
11.
Zhang, Lu, Bridget Riley‐Gillis, Priyanka Vijay, & Yu Shen. (2019). Acquired Resistance to BET-PROTACs (Proteolysis-Targeting Chimeras) Caused by Genomic Alterations in Core Components of E3 Ligase Complexes. Molecular Cancer Therapeutics. 18(7). 1302–1311. 231 indexed citations
12.
Weiss, Anna, Heather Lin, Yu Shen, et al.. (2018). Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Research and Treatment. 169(3). 615–623. 14 indexed citations
13.
Ning, Jing, Chuan Hong, Liang Li, Xuelin Huang, & Yu Shen. (2017). Estimating treatment effects in observational studies with both prevalent and incident cohorts. Canadian Journal of Statistics. 45(2). 202–219. 7 indexed citations
14.
Lam, Lloyd T., Xiaoyu Lin, Emily J. Faivre, et al.. (2017). Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors. Molecular Cancer Therapeutics. 16(8). 1511–1520. 55 indexed citations
15.
Faivre, Emily J., Denise Wilcox, Xia Li, et al.. (2016). Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075. Molecular Cancer Research. 15(1). 35–44. 53 indexed citations
16.
Lin, Xiaoyu, Xiaoli Huang, Tamar Uziel, et al.. (2016). HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues. Molecular Cancer Therapeutics. 16(2). 388–396. 45 indexed citations
17.
Tang, Derek Ng, Yu Shen, Jingjing Sun, et al.. (2013). Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy. Cancer Immunology Research. 1(4). 229–234. 146 indexed citations
18.
Chen, Jun, Sha Jin, Xiaoli Huang, et al.. (2011). The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo. Molecular Cancer Therapeutics. 10(12). 2340–2349. 119 indexed citations
19.
Li, Xia, Navdeep S. Chandel, Xiaoli Huang, et al.. (2008). A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation. Proceedings of the National Academy of Sciences. 105(1). 174–179. 85 indexed citations
20.
Sharma, Padmanee, Yu Shen, Sijin Wen, et al.. (2006). Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma. Clinical Cancer Research. 12(18). 5442–5447. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Le Tourneau Breakdown of academic impact, for papers by B. Nebiyou Bekele Breakdown of academic impact, for papers by Sin‐Ho Jung Breakdown of academic impact, for papers by Rajeshwari Sridhara Breakdown of academic impact, for papers by Gary Longton Breakdown of academic impact, for papers by Matthew R. Sydes Breakdown of academic impact, for papers by Alberto Ocaña Breakdown of academic impact, for papers by Nicholas D. James Breakdown of academic impact, for papers by Patricia Keegan Breakdown of academic impact, for papers by Kristine Broglio
Rankless by CCL
2026